The thrombogenic potential of Covid-19 is recognised and we read with interest the case
series of 22 patients presented by Mueller-Peltzer and colleagues [1]. Their findings of …

Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with …

SARS-CoV-2 (COVID-19) is associated with increased thrombosis. Here, we demonstrate
patterns of pulmonary vascular disease in COVID-19 including classical acute pulmonary …

I have read with great interest the recent article by Klok et al., showing that the cumulative
incidence of thrombotic complications in patients with COVID-19 admitted to the intensive …

We read with great interest the recent article by Demelo-Rodríguez et al., reporting that the
incidence of (asymptomatic) deep vein thrombosis (DVT) in patients admitted with COVID-19 …

We read with great interest the recent article by LF van Dam et al. entitled “Clinical and
computed tomography characteristics of COVID-19 associated acute pulmonary embolism …

An increased incidence of thrombotic complications has been described in COVID-19
patients, particularly in those with severe disease and/or admitted to the intensive care unit …

Research on COVID-19, the cause of a rapidly worsening pandemic, has led to the
observation of laboratory derangements such as a propensity towards a hypercoagulable …

Background A considerable number of SARS-CoV-2 infected individuals could be
asymptomatic and don't need medical treatment. The clinical spectrum of SARS-CoV-2 …

There is some evidence that Covid 19 pneumonia is associated with prothrombotic status
and increased risk of venous thromboembolic events (deep venous thrombosis and …